Esther Hong
Stock Analyst at Loop Capital
(0.12)
# 3,289
Out of 4,479 analysts
19
Total ratings
11.11%
Success rate
-39.01%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNOX Bionomics | Maintains: Buy | $10 → $17 | $0.71 | +2,302.83% | 3 | Mar 9, 2023 | |
| CERE Cerevel Therapeutics Holdings | Initiates: Buy | $40 | $41.23 | -2.98% | 1 | Nov 1, 2022 | |
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.30 | +1,284.62% | 1 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $15.84 | +7.32% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $5.96 | +470.47% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $78.93 | +20.36% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $10.82 | +278.93% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $1.31 | +53.26% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $2.52 | +1,209.52% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $3.80 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | n/a | $3.25 | - | 2 | Dec 16, 2020 |
Bionomics
Mar 9, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.71
Upside: +2,302.83%
Cerevel Therapeutics Holdings
Nov 1, 2022
Initiates: Buy
Price Target: $40
Current: $41.23
Upside: -2.98%
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.30
Upside: +1,284.62%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $15.84
Upside: +7.32%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $5.96
Upside: +470.47%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $78.93
Upside: +20.36%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $10.82
Upside: +278.93%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $1.31
Upside: +53.26%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $2.52
Upside: +1,209.52%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $3.80
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: n/a
Current: $3.25
Upside: -